ARCHIVES

Contract Authority Expiration Confuses NCI Money Bill Estimates, Which Range From $605 To $650 Million

This article is from The Cancer Letter archive.

Vol. 01 No. 20 | June 21, 1974

Download PDF Visit The Full Archive

Related Articles

FDA Approves New Drug for Advanced Kidney Cancer

May 25, 2007

Vaccine and LDCT Pretreatment Can Help PDACs Become Vulnerable to Immunotherapy

June 27, 2014

Review Guidelines For Comprehensive Centers Drafted, NCAB To Consider at December Meeting

November 24, 1989

NCI’s $65 Million to NTP Will Be Controversial, Untouchable; Spectre Of Another Backlog Looms

February 8, 1980

Phase III Kyprolis Trial Fails OS Primary Endpoint

August 29, 2014

In Brief: Komen Foundation Awards Honor Gingell, Osborne, Freeman; Tobacco Regulation Urged

October 21, 1994